194 related articles for article (PubMed ID: 24009295)
1. Sensitization from transfusion in patients awaiting primary kidney transplant.
Yabu JM; Anderson MW; Kim D; Bradbury BD; Lou CD; Petersen J; Rossert J; Chertow GM; Tyan DB
Nephrol Dial Transplant; 2013 Nov; 28(11):2908-18. PubMed ID: 24009295
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation.
Leffell MS; Kim D; Vega RM; Zachary AA; Petersen J; Hart JM; Rossert J; Bradbury BD
Transplantation; 2014 Mar; 97(5):525-33. PubMed ID: 24300013
[TBL] [Abstract][Full Text] [Related]
3. Effect of Single Sensitization Event on Human Leukocyte Antigen Alloimmunization in Kidney Transplant Candidates: A Single-Center Experience.
Resse M; Paolillo R; Pellegrino Minucci B; Costa D; Fiorito C; Santangelo M; De Rosa P; Napoli C
Exp Clin Transplant; 2018 Feb; 16(1):44-49. PubMed ID: 28661314
[TBL] [Abstract][Full Text] [Related]
4. Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion.
Balasubramaniam GS; Morris M; Gupta A; Mesa IR; Thuraisingham R; Ashman N
Transplantation; 2012 Feb; 93(4):418-22. PubMed ID: 22228416
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Complement-Binding Capacity of HLA Antibodies Based on Mean Fluorescence Intensity.
Zhao J; Fu YX; Yang T; Shen ZY; Wu CL
Transplant Proc; 2016; 48(6):2235-40. PubMed ID: 27569975
[TBL] [Abstract][Full Text] [Related]
6. Effects of HLA-matched blood transfusion for patients awaiting renal transplantation.
Magee BA; Martin J; Cole MP; Morris KG; Courtney AE
Transplantation; 2012 Dec; 94(11):1111-6. PubMed ID: 23111496
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients.
Hung SY; Lin TM; Chang MY; Wang HH; Lee YC; Ho LC; Chen YT; Hung CM; Liou HH
Hum Immunol; 2014 Jun; 75(6):531-5. PubMed ID: 24607727
[TBL] [Abstract][Full Text] [Related]
8. Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.
Bynum JP; Zachary A; Ness PM; Luo X; Bagnasco S; King KE; Segev DL; Orandi BJ; Warren DS; Fuller A; Ciappi A; Montgomery R; Tobian AAR
Transfusion; 2018 Aug; 58(8):1951-1957. PubMed ID: 30171817
[TBL] [Abstract][Full Text] [Related]
9. Significance of the intraindividual variability of HLA IgG antibodies in renal disease patients observed with different beadsets monitored with two different secondary antibodies on a Luminex platform.
Ravindranath MH; Filippone EJ; Mahowald G; Callender C; Babu A; Saidman S; Ferrone S
Immunol Res; 2018 Oct; 66(5):584-604. PubMed ID: 30324227
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
[TBL] [Abstract][Full Text] [Related]
11. De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation.
Heilman RL; Nijim A; Desmarteau YM; Khamash H; Pando MJ; Smith ML; Chakkera HA; Huskey J; Valdez R; Reddy KS
Transplantation; 2014 Dec; 98(12):1310-5. PubMed ID: 24879384
[TBL] [Abstract][Full Text] [Related]
12. De novo produced anti-human leukocyte antigen antibodies relation to alloimmunity in patients with chronic renal failure.
Pirim I; Soyoz M; Ayna TK; Kocyigit AO; Gurbuz BC; Tugmen C; Kurtulmus Y; Ozyilmaz B
Genet Test Mol Biomarkers; 2015 Jun; 19(6):335-8. PubMed ID: 25826018
[TBL] [Abstract][Full Text] [Related]
13. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
[TBL] [Abstract][Full Text] [Related]
14. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
Akgul SU; Ciftci HS; Temurhan S; Caliskan Y; Bayraktar A; Tefik T; Kaya IA; Canitez IO; Demir E; Yazici H; Bakkaloglu H; Aydin AE; Turkmen A; Nane I; Aydin F; Oguz FS
Transplant Proc; 2017 Apr; 49(3):425-429. PubMed ID: 28340805
[TBL] [Abstract][Full Text] [Related]
15. Effects of different sensitization events on HLA alloimmunization in solid organ transplantation patients.
Hyun J; Park KD; Yoo Y; Lee B; Han BY; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):222-5. PubMed ID: 22310619
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Donor-Specific Anti-Human Leukocyte Antigen (HLA) Antibody Rebound on the Risk of Antibody Mediated Rejection in Sensitized Kidney Transplant Recipients.
Lee KW; Park JB; Cho CW; Lee N; Yoo H; Kim K; Park H; Kang ES; Huh W; Kim S
Ann Transplant; 2017 Mar; 22():166-176. PubMed ID: 28348361
[TBL] [Abstract][Full Text] [Related]
17. One-Year Outcomes of Living Related Kidney Transplant in Patients With Preformed HLA Donor-Specific Antibodies: A Single-Center Experience in Malaysia.
Jalalonmuhali M; Ng KP; Mohd Shariff NH; Lee YW; Wong AH; Gan CC; Lim SK
Transplant Proc; 2020; 52(6):1718-1722. PubMed ID: 32448671
[TBL] [Abstract][Full Text] [Related]
18. Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis.
Manook M; Koeser L; Ahmed Z; Robb M; Johnson R; Shaw O; Kessaris N; Dorling A; Mamode N
Lancet; 2017 Feb; 389(10070):727-734. PubMed ID: 28065559
[TBL] [Abstract][Full Text] [Related]
19. HLA and MICA allosensitization patterns among patients supported by ventricular assist devices.
Askar M; Hsich E; Reville P; Nowacki AS; Baldwin W; Bakdash S; Daghstani J; Zhang A; Klingman L; Smedira N; Moazami N; Taylor DO; Starling RC; Gonzalez-Stawinski G
J Heart Lung Transplant; 2013 Dec; 32(12):1241-8. PubMed ID: 24075503
[TBL] [Abstract][Full Text] [Related]
20. Panel reactive antibodies in predicting hepatitis C virus treatment outcome in kidney transplant candidates.
Öcal S; Harmancı Ö; Korkmaz M; Ensaroğlu F; Çolak T; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():193-6. PubMed ID: 25894153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
